Kiely John 4
4 · Amneal Pharmaceuticals, Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Kiely John
Director
Transactions
- Sale
Class A Common Stock
2024-11-22$8.38/sh−17,058$142,946→ 267,175 total - Exercise/Conversion
Class A Common Stock
2024-11-22$4.76/sh+28,506$135,689→ 284,233 total - Exercise/Conversion
Stock Option
2024-11-22−28,506→ 0 totalExercise: $4.76Exp: 2029-12-14→ Class A Common Stock (28,506 underlying)
Footnotes (2)
- [F1]Reflects shares sold to cover the exercise price arising in connection with the exercise of the stock options.
- [F2]The option is vested and currently exercisable.